Found: 964
Select item for more details and to access through your institution.
Cardioprotective Effects of 'Vasant Kusumakar Rasa,' a Herbo-metallic Formulation, in Type 2 Diabetic Cardiomyopathy in Rats.
- Published in:
- Cardiovascular Toxicology, 2024, v. 24, n. 9, p. 942, doi. 10.1007/s12012-024-09891-0
- By:
- Publication type:
- Article
SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs.
- Published in:
- Cardiovascular Toxicology, 2024, v. 24, n. 6, p. 598, doi. 10.1007/s12012-024-09858-1
- By:
- Publication type:
- Article
Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death.
- Published in:
- Cardiovascular Toxicology, 2024, v. 24, n. 2, p. 71, doi. 10.1007/s12012-024-09836-7
- By:
- Publication type:
- Article
Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 9/10, p. 295, doi. 10.1007/s12012-023-09804-7
- By:
- Publication type:
- Article
LncRNA MALAT1 Regulates USP22 Expression Through EZH2-Mediated H3K27me3 Modification to Accentuate Sepsis-Induced Myocardial Dysfunction.
- Published in:
- Cardiovascular Toxicology, 2022, v. 22, n. 9, p. 813, doi. 10.1007/s12012-022-09758-2
- By:
- Publication type:
- Article
Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia–Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
- Published in:
- Cardiovascular Toxicology, 2020, v. 20, n. 2, p. 155, doi. 10.1007/s12012-019-09542-9
- By:
- Publication type:
- Article
Beneficial Role of Some Natural Products to Attenuate the Diabetic Cardiomyopathy Through Nrf2 Pathway in Cell Culture and Animal Models.
- Published in:
- Cardiovascular Toxicology, 2018, v. 18, n. 3, p. 199, doi. 10.1007/s12012-017-9430-2
- By:
- Publication type:
- Article
Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Cyp2e1 knockdown attenuates high glucose-induced apoptosis and oxidative stress of cardiomyocytes by activating PI3K/Akt signaling.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 9, p. 1219, doi. 10.1007/s00592-023-02110-2
- By:
- Publication type:
- Article
Long non-coding RNA KCNQ1OT1 increases the expression of PDCD4 by targeting miR-181a-5p, contributing to cardiomyocyte apoptosis in diabetic cardiomyopathy.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 9, p. 1251, doi. 10.1007/s00592-021-01713-x
- By:
- Publication type:
- Article
Silencing lncRNA GAS5 alleviates apoptosis and fibrosis in diabetic cardiomyopathy by targeting miR-26a/b-5p.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 11, p. 1491, doi. 10.1007/s00592-021-01745-3
- By:
- Publication type:
- Article
Evidence for human diabetic cardiomyopathy.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 8, p. 983, doi. 10.1007/s00592-021-01705-x
- By:
- Publication type:
- Article
Diabetic cardiomyopathy: How can cardiac magnetic resonance help?
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 9, p. 1027, doi. 10.1007/s00592-020-01528-2
- By:
- Publication type:
- Article
LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 51, n. 2, p. 1230
- By:
- Publication type:
- Article
Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 50, n. 5, p. 1726, doi. 10.1159/000494791
- By:
- Publication type:
- Article
LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 50, n. 4, p. 1230, doi. 10.1159/000494576
- By:
- Publication type:
- Article
Identification of Energy Metabolism Changes in Diabetic Cardiomyopathy Rats Using a Metabonomic Approach.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 48, n. 3, p. 934, doi. 10.1159/000491960
- By:
- Publication type:
- Article
Neuregulin-1 Promotes Myocardial Angiogenesis in the Rat Model of Diabetic Cardiomyopathy.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 46, n. 6, p. 2325, doi. 10.1159/000489622
- By:
- Publication type:
- Article
Type I Diabetic Akita Mouse Model is Characterized by Abnormal Cardiac Deformation During Early Stages of Diabetic Cardiomyopathy with Speckle-Tracking Based Strain Imaging.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 45, n. 4, p. 1541, doi. 10.1159/000487690
- By:
- Publication type:
- Article
H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 43, n. 4, p. 1311, doi. 10.1159/000481843
- By:
- Publication type:
- Article
The Sodium-Glucose Co-Transporter 2 Inhibitor, Empagliflozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 1, p. 2503, doi. 10.1159/000475942
- By:
- Publication type:
- Article
The Sodium-Glucose Co-Transporter 2 Inhibitor, Empaglifozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 41, n. 6, p. 2503, doi. 10.1159/000475942
- By:
- Publication type:
- Article
Lipotoxic Palmitate Impairs the Rate of β-Oxidation and Citric Acid Cycle Flux in Rat Neonatal Cardiomyocytes.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 40, n. 5, p. 969, doi. 10.1159/000453154
- By:
- Publication type:
- Article
Role of the integrin-linked kinase/TGF-β/SMAD pathway in sitagliptin-mediated cardioprotective effects in a rat model of diabetic cardiomyopathy.
- Published in:
- Journal of Pharmacy & Pharmacology, 2024, v. 76, n. 1, p. 64, doi. 10.1093/jpp/rgad111
- By:
- Publication type:
- Article
Cardioprotection of Eucommiae Folium: the extract and pharmaceutically active compounds attenuate hyperglycemia, mitochondrial dysfunction, calcium dyshomeostasis, insulin resistance, and oxidative stress in diabetic cardiomyopathy db/db mice.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 12, p. 1509, doi. 10.1093/jpp/rgad095
- By:
- Publication type:
- Article
Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: possible involvement of PDE-1/TGF-β/ Smad 2/3 signalling pathways.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 9, p. 1198, doi. 10.1093/jpp/rgad043
- By:
- Publication type:
- Article
The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathy.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 12, p. 1663, doi. 10.1093/jpp/rgac066
- By:
- Publication type:
- Article
Exogenous hydrogen sulphide ameliorates diabetic cardiomyopathy in rats by reversing disordered calcium-handling system in sarcoplasmic reticulum.
- Published in:
- Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 3, p. 379, doi. 10.1111/jphp.12517
- By:
- Publication type:
- Article
Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway.
- Published in:
- BMC Complementary Medicine & Therapies, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12906-021-03218-0
- By:
- Publication type:
- Article
Cardioprotective effects of polydatin against myocardial injury in diabetic rats via inhibition of NADPH oxidase and NF-κB activities.
- Published in:
- BMC Complementary Medicine & Therapies, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12906-020-03177-y
- By:
- Publication type:
- Article
Deep sea minerals ameliorate diabetic‐induced inflammation via inhibition of TNFα signaling pathways.
- Published in:
- Environmental Toxicology, 2020, v. 35, n. 4, p. 468, doi. 10.1002/tox.22882
- By:
- Publication type:
- Article
Sleep restriction exacerbates cardiac dysfunction in diabetic mice by causing cardiomyocyte death and fibrosis through mitochondrial damage.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02214-w
- By:
- Publication type:
- Article
Harnessing the Synergy of SGLT2 Inhibitors and Continuous Ketone Monitoring (CKM) in Managing Heart Failure among Patients with Type 1 Diabetes.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 7, p. 753, doi. 10.3390/healthcare12070753
- By:
- Publication type:
- Article
血清硫氧还蛋白相互作用蛋白、Ⅲ型纤维蛋白结构域结合蛋白 5 与糖尿病性心肌病的相关性及诊断价值分析.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 14, p. 2683, doi. 10.13241/j.cnki.pmb.2023.14.015
- By:
- Publication type:
- Article
阿托伐他汀通过RGS6 改善糖尿病心肌病大鼠心功能的作用 及其机制研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 15, p. 2848, doi. 10.13241/j.cnki.pmb.2020.15.009
- By:
- Publication type:
- Article
MiR-146a 通过炎症参与小鼠糖尿病心肌病的机制研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 5, p. 848, doi. 10.13241/j.cnki.pmb.2020.05.010
- By:
- Publication type:
- Article
人参皂苷Rb1通过上调PGC-1α缓解糖尿病心肌病.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 1, p. 19, doi. 10.13241/j.cnki.pmb.2020.01.004
- By:
- Publication type:
- Article
从瘀毒角度论述糖尿病心肌病的病因病机.
- Published in:
- Journal of Beijing University of Traditional Chinese Medicine, 2023, v. 46, n. 2, p. 181, doi. 10.3969/j.issn.1006-2157.2023.02.007
- By:
- Publication type:
- Article
Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.
- Published in:
- Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/8905917
- By:
- Publication type:
- Article
Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats.
- Published in:
- Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/9232065
- By:
- Publication type:
- Article
Investigating Celastrol's Anti-DCM Targets and Mechanisms via Network Pharmacology and Experimental Validation.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/7382130
- By:
- Publication type:
- Article
Cardioprotection by Citrus grandis (L.) Peel Ethanolic Extract in Alloxan-Induced Cardiotoxicity in Diabetic Rats.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/2807337
- By:
- Publication type:
- Article
Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/3764370
- By:
- Publication type:
- Article
Cardioprotective effect of extracellular vesicles derived from ticagrelor-pretreated cardiomyocyte on hyperglycemic cardiomyocytes through alleviation of oxidative and endoplasmic reticulum stress.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09627-6
- By:
- Publication type:
- Article
Cardioprotective potential of N-acetyl cysteine against hyperglycaemia-induced oxidative damage: a protocol for a systematic review.
- Published in:
- Systematic Reviews, 2017, v. 6, p. 1, doi. 10.1186/s13643-017-0493-8
- By:
- Publication type:
- Article
Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1146651
- By:
- Publication type:
- Article
Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1166653
- By:
- Publication type:
- Article
The role of β-catenin in cardiac diseases.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1157043
- By:
- Publication type:
- Article
Bibliometric and visualized analysis of sodium--Glucose cotransporter 2 inhibitors.
- Published in:
- Frontiers in Pharmacology, 2023, v. 13, p. 01, doi. 10.3389/fphar.2022.1009025
- By:
- Publication type:
- Article
NOX1 promotes myocardial fibrosis and cardiac dysfunction via activating the TLR2/NF-κB pathway in diabetic cardiomyopathy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.928762
- By:
- Publication type:
- Article